Abstract
During myelination, individual oligodendrocytes initially over-produce short myelin sheaths that are either retracted or stabilised. By live imaging oligodendrocyte Ca2+ activity in vivo, we find that high-amplitude long-duration Ca2+ transients in sheaths prefigure retractions, mediated by calpain. Following stabilisation, myelin sheaths grow along axons, and we find that higher frequency Ca2+ transient activity in sheaths precedes faster elongation. Our data implicate local Ca2+ signalling in regulating distinct stages of myelination.
Dynamic regulation of myelination by oligodendrocytes in the central nervous system (CNS) is essential for nervous system development and life-long function1, but our understanding of myelin sheath formation and growth is limited. Zebrafish are well suited to studying the dynamics of CNS myelination in vivo, due to their capacity for non-invasive longitudinal imaging. Previous imaging studies using zebrafish have shown that individual oligodendrocytes initiate formation and elongation of their myelin sheaths within a critical period of about 5 hours2,3, mirroring hours-long myelin sheath generation by mammalian oligodendrocytes in vitro4. During sheath formation, myelinating oligodendrocytes initially overproduce short myelin sheaths (circa 5µm in length), with some stabilised, and others fully retracted2,3,5,6. Following stabilisation, myelin sheaths grow along and around associated axons3, to achieve dimensions that mediate the timing of impulse conduction and thus neural circuit function7. Although axonal signals, including neuronal activity, can regulate the formation and growth of myelin sheaths (e.g.5,8–10), the localised signalling mechanisms that control the dynamics of myelination by oligodendrocytes remain to be elucidated.
Ca2+ is a second messenger that regualtes many events, and localised Ca2+ activity has been observed in oligodendrocyte precursor cells11, myelinating oligodendrocytes10, and even in mature myelin sheaths12 in vitro and ex vivo. We reasoned that determining how localised Ca2+ activity relates to the formation and growth of myelin sheaths in vivo would provide novel insights into mechanisms of CNS myelination.
To visualise Ca2+ activity in myelinating oligodendrocytes, we used the genetically encoded calcium indicator GCaMP6s13, which we expressed in oligodendrocytes by crossing Tg(sox10:KalTA4) and Tg(uas:GCaMP6s) transgenic zebrafish lines (Online Methods). We imaged GCaMP6s expressing oligodendrocytes in the spinal cord of zebrafish larvae between 3-4 days post fertilisation (dpf), as myelin sheaths are being formed and starting to elongate2,3. We first assessed the kinetics of individual localised Ca2+ transients in myelin sheaths by high-speed 2D (4Hz) imaging, and found that essentially all transients lasted longer than 3.5 seconds (Supplementary Fig. 1, Supplementary Movie 1). Therefore, we 3D imaged Ca2+ activity in all myelin sheaths belonging to individual oligodendrocytes with a time interval of 2.5 seconds (Fig. 1A-E, Online Methods, Supplementary Fig. 2, and Supplementary Movies 2 and 3).
To correlate Ca2+ activity with myelination, we time-lapse imaged individual GCaMP6s-expressing oligodendrocytes for multiple 20 minute blocks over a 5-9 hour period during which they initiated formation and elongation of their myelin sheaths (Fig. 1F,G). Prior to each Ca2+ imaging block, we acquired a high-resolution 3D z-stack of GCaMP6s-expressing oligodendrocytes together with sox10:mRFP, which allowed assessment of sheath morphology (Fig. 1F,G and see Online Methods). We quantified the Ca2+ activity of 305 sheaths of 18 oligodendrocytes in 18 animals. Analyses of 448 Ca2+ transients in the 187 sheaths that exhibited activity (out of the 305 sheaths imaged) revealed significant diversity in the frequency (Fig.1H), amplitude and duration of transients between sheaths (Fig. 1I,J) (Median amplitude per sheath ΔF/F0= 0.7, IQR=0.9; Median Ca2+ transient duration= 23s, IQR=17 seconds per sheath). We also found that duration and amplitude were positively correlated, whereby longer duration transients tended to also be of higher amplitude (Fig. 1K).
The diversity in Ca2+ transient activity between sheaths suggested that their frequency, duration and/or amplitude may influence myelination. We first focussed on the relationship between Ca2+ activity and myelin sheath formation. We found that 61 of the 305 sheaths analysed were completely retracted during our imaging protocol, reflecting the initial over-production of sheaths. Intriguingly, we found that the amplitude of Ca2+ transients in sheaths that were subsequently retracted was three-fold higher than in those sheaths that were stabilised (Fig. 2A,B,D: Median amplitude =1.8 ΔF/F0 in fully retracted sheaths vs 0.6 ΔF/F0 in stabilised sheaths). Furthermore, we observed an increase in Ca2+ transient duration in sheaths that were subsequently retracted (Fig.2C,D: Median duration= 35s in retracted sheaths vs 22s in stabilised). Interestingly, the Ca2+ transients observed in sheaths that were subsequently retracted travelled from sheath to process (Supplementary Fig. 3, Supplementary Movie 4), reflecting the directionality of retraction, first of the sheath and then the process (Fig. 2A, Supplementary Fig. 4). These observations lead us to hypothesise that localised high-amplitude long-duration Ca2+ transients may mediate sheath retraction through activation of Ca2+-dependent mechanisms.
We hypothesised that calpain enzymes, Ca2+ dependent non-lysosomal proteases, might mediate sheath retraction. Calpains underpin many aspects of cellular breakdown, including the localised pruning of dendrites in Drosophila following large Ca2+ transients14. To test whether calpain mediates myelin sheath retractions, we took chemical and genetic approaches. We first treated animals with the calpain inhibitor PD15060615 from 2-4 dpf, and assessed the morphology of individual oligodendrocytes with mbp:mCherry-CAAX 6. We found that PD150606 treatment increased myelin sheath number per oligodendrocyte (Fig. 2E,H) (Average sheath number per oligodendrocyte: DMSO 14.4±3.2 vs PD150606 18.7±5.9). In order to whether calpain actually mediates retraction of sheaths, we carried out time-lapse microscopy of PD150606-treated animals. These studies revealed a lower rate of sheath retraction in calpain-inhibited animals during the dynamic period of sheath stabilisation and retraction (Fig. 2F,I and Supplementary movies 5+6) (Sheath retraction per oligodendrocyte per hour, DMSO 0.34±0.13 vs PD150606 0.24±0.13). To independently and cell autonomously test the role for calpain in regulating myelin sheath number, we expressed the endogenous inhibitor of calpain, calpastatin16, in myelinating oligodendrocytes (see Online Methods and Supplementary Fig. 5). Analysis of oligodendrocyte morphology revealed that cell-type specific disruption of calpain protease function increased the number of myelin sheaths compared to control (Fig. 2G,J) (Average sheath number per cell mbp:meGFP 15.8±6.4 vs mbp:meGFP-calpastatin 20.5±5.8).
Together, these data support our imaging-driven hypothesis that calpain regulates retraction of myelin sheaths during the dynamic period of myelin sheath formation by individual oligodendrocytes.
We next assessed how Ca2+ transient activity might relate to myelin sheath growth. By comparing Ca2+ activity and differential growth over time (Fig. 3A,B), we found that the frequency of the lower amplitude shorter duration Ca2+ transients observed in stabilised sheaths correlated positively with the speed of sheath elongation (Fig. 3C,D). Interestingly, when we analysed how individual sheaths grew after each Ca2+ transient, we observed positive elongation within the first 2 hours of the Ca2+ transient (Fig. 3E). We did not see any correlation between the average amplitude or duration of transients with the speed of growth (Supplementary Fig. 6). These observations show the frequency of low amplitude short duration Ca2+ transients in stabilised sheaths is predictive of their speed of elongation, suggesting that dynamic changes in myelin sheath Ca2+ concentration regulate sheath growth.
Our live imaging has revealed distinct signatures of localised Ca2+ activity during CNS myelination. High-amplitude long duration Ca2+ transients precede localised retraction of sheaths, mediated by calpain, whereas the frequency of lower amplitude shorter duration transients in stabilised sheaths correlates positively with their speed of elongation (Summarised in Supplementary Fig. 7). How could distinct Ca2+ signatures lead to such different outcomes during myelination? With respect to sheath retraction, it is known that different isoforms of calpain have distinct sensitivities to Ca2+ concentration, with some primed for activation by localised changes in Ca2+ concentration17. It is possible that large localised increases in Ca2+ concentration following individual high-amplitude long-duration transients could stimulate local protease activity that leads to sheath retraction, e.g. by localised degradation of cytoskeletal components. With respect to the speed of sheath elongation, it is now known that myelin sheath growth occurs is driven at inside of the myelin sheath3, at least in part, by iterative cycles of actin polymerisation and depolymerisation18. Given that actin polymerisation/depolymerisation can be regulated by Ca2+, it is possible that localised changes in Ca2+ concentration could affect the speed of sheath growth via regulating the actin cytoskeleton.
Many additional questions remain as to how localised Ca2+ regulates myelination. Which signal(s) lead to the distinct changes in myelin sheath Ca2+ during retraction, stabilisation and growth? Neuronal activity is one signal known to affect myelination5,8–10, and many of its candidate mediators in oligodendrocytes converge on regulation of intracellular Ca2+ 19. Indeed, a complementary study to ours indicates that neuronal activity regulates about half of the Ca2+ transients in myelin20. How Ca2+ might affect ongoing sheath growth and remodelling throughout life, and during regeneration, also remain to be investigated. We anticipate that live Ca2+ imaging-focussed approaches will continue to elucidate the mechanisms underlying the dynamic regulation of myelination in the CNS.
Online Methods
Zebrafish husbandry
All animal studies were carried out with approval from the UK Home Office and according to its regulations, under project licenses 60/ 8436 and 70/8436. The project was approved by the University of Edinburgh Institutional Animal Care and Use Committee. We used zebrafish (Danio rerio) only, and the following transgenic lines in this study: tg(sox10(7.2):KalTA4GI)21, tg(UAS:mem-GFP), tg(uas:GCaMP6s)13 and tg(sox10:mRFP)22. All Ca2+ imaging was carried out in the nacre background23, which lack melanocytes.
Image acquisition
We combined stable transgenic zebrafish Tg(sox10:KalTA4), which drives gene expression in the oligodendrocyte lineage, with Tg(uas:GCaMP6s) that expresses the genetically encoded calcium indicator GCaMP6s under the control of 14X repetitive Upstream Activator Sequences (uas), the nacre homozygous mutant line that lacks melanocytes, and also Tg(sox10:mRFP) which drives membrane localised RFP expression in the myelinating oligodendrocyte lineage. The combination of Tg(sox10:KalTA4) and Tg(uas:GCaMP6s) leads to mosaic expression of GCaMP6s in isolated cells of the oligodendrocyte lineage in the CNS.
Prior to imaging, larvae were screened for the expression of GCaMP6s in isolated oligodendrocytes in the dorsal spinal cord at 3-4 days post fertilisation (dpf). Selected larvae were paralysed using the Neuromuscular Junction (NMJ) blocking nicotinic receptor antagonist pancuronium bromide (Sigma, P1918), which was dissolved in embryo medium (0.15-0.3mg/ml). Larvae were then embedded in 1.3% agarose for imaging. Imaging was carry out on an Olympus Revolution XDi spinning disk confocal microscope using a 1.2 NA 60X water immersion objective, plus a camera zoom of 2X, giving an X-Y image area of 117x117µm and acquisition at 512x512 pixels. Larvae were maintained at 28°C in temperature controlled chamber (Okolab). Images were acquired using the iQ3 software (Andor) and iXon EMCCD Ultra 897 camera.
For initial 2D characterisation of calcium transient kinetics, Tg(sox10:KalTA4, uas:GCaMP6s), Tg(sox10:mRFP) larva were time-lapse imaged for periods of 10-30 min with 100ms exposure time, and 150-250ms intervals, reflecting imaging in one (GCaMP6s) or two (GCaMP6s and mRFP) channels, for a final rate of 4-6.66 Hz (final rates also incorporate camera integration times).
To investigate how Ca2+ activity related to cell fate, Tg(sox10:KalTA4, uas:GCaMP6s, sox10:mRFP), nacre-/- larva were imaged every 60-120 min as follows. First, one high-resolution 3D 29µm deep (average±2µm) z-stack of both RFP and GCaMP6s expression was acquired at 100ms exposure, 4x averaging, and z-intervals between optical slices of 0.33µm. Immediately thereafter, 3D time-lapse images of GCaMP6s expression alone were acquired of the same 29µm (±2µm) volume, at 100ms exposure (no averaging), and z step of 1.3µm. The time interval between consecutive z-stacks in the time-lapse was 2.538s (±0.264s), including z-positioning and camera integration times. Absolute values of imaging parameters were incorporated into analyses of all individual Ca2+ transients and time-lapse data.
Image analysis
2D time-lapse imaging data were analysed using Fiji. To correct for sample drift throughout the movie we used the “Image stabilizer registration” Fiji plugin (Kang Li). Because of the very sparse labelling of individual GCaMP6s expressing oligodendrocytes it is possible to identify Ca2+ transients by manual inspection of time-lapse series. Regions of interest are then applied around all myelin sheaths and also in a separate area with no GCaMP6s expression, which represents background. Then fluorescent intensity measurements are extracted from both ROIs and imported into Excel. To measure ΔF/F0 we apply the following formula: ΔF/F0= (F(t)-F(0))/(F(0)-F(background)) where F(t) is the fluorescence intensity in the ROI in which the Ca2+ transient was observed at time (t), F(0) the average fluorescence intensity of the first 4 frames of the movie in the same ROI and F(background) the fluorescence intensity of the background ROI at time (t). See Supplementary Figure 1 for overview. This ΔF/F0 information and corresponding image acquisition parameters are imported into pClamp (Molecular Devices) for detailed analyses of the duration and amplitude of individual Ca2+ transients.
For 3D time-lapse imaging data, maximum intensity projections of the individual time-points from 3D time-lapse data were made using Fiji and the image stabilizer Fiji plugin was again run to account for drift. In parallel 3D datasets were registered using the “Descriptor-based series registration (2d/3d+t)” Fiji plugin, after which maximum intensity projections are made and Ca2+ transients identified manually. Ca2+ transients were then identified manually. Only Ca2+ transients identified following both modes of image processing were considered as valid. All myelin sheaths without overlapping structures in the X-Y or Z planes were analysed. Regions of interest are then applied around all myelin sheaths and corresponding background, as above. In addition, the ROI with the candidate Ca2+ transient was moved to an immediately adjacent region in order to rule out the possibility that any, very infrequent, general increase in background fluorescence in the region could identify a spurious transient. Key parameters for analysis of 3D time-lapse datasets were extracted from the iQ3 metadata files using a custom-written Fiji macro written by Dr. Bertrand Vernay, University of Edinburgh. These parameters were then imported into Microsoft Excel for analysis. All Ca2+ transients were identified by ΔF/F(0) as above and analysed using pClamp.
To measure myelin sheath length, we used the 3D high-resolution single time z-stack datasets acquired before each period of GCaMP6s time-lapse imaging. The expression of GCaMP6s allowed identification of individual myelin sheaths and the membrane localised mRFP in the same sheaths allowed more accurate measurement of length.
Calpain inhibitor treatment and analysis
The calpain inhibitor PD150606 (Tocris) was applied in solution from 50µM -75µM with 1% DMSO to embryos from 2-4 dpf and vehicle alone applied to controls. The morphology of myelinating oligodendrocytes was assessed as previously by imaging individual oligodendrocytes expressing the mbp:mCherry-CAAX reporter6. Images of individual myelinating oligodendrocytes were taken on a Zeiss 880 with Airyscan, in animals immobilized using 1.3% Low melting point agarose with 0.03% Tricaine in embryo medium. Individual myelin sheaths were identified in 3D z-stacks and measured using Fiji. Time-lapse analyses were carried out using tg(sox10(7.2):KalTA4GI), tg(UAS:mem-GFP), animals, which were imaged on a Zeiss 880 Airyscan in Fast Mode and with a piezo z-drive to allow rapid acquisition of confocal z-stacks. Z-stack images were collected every 5 minutes for a 15 hour period from 81-96 hpf.
Cell-type specific expression of calpastatin in myelinating oligodendrocytes
In order to disrupt calpain function in a cell type specific manner, we chose to express the endogenous inhibitor of calpain, calpastatin24, in myelinating oligodendrocytes. We first cloned zebrafish calpastatin. To do so, we extracted mRNA from whole zebrafish embryos at 3 and 4 dpf, generated cDNA and amplified calpastatin using the following primers castF: 5’- ATGGCGTACGCAATGTATTGG -3’; castR: 5’-TTATCTTTTTCCAGCCTTTGTGG-3’ and high fidelity Phusion polymerase (Thermo Fisher). We cloned cast fragments into pCR™-Blunt II-TOPO™ (Thermo Fisher) and Sanger sequenced clones (Source Bioscience). We subcloned multiple cast mRNA variants into pCS2+ and generated synthetic mRNA, which we injected into animals at the one cell stage to identify full-length version that lead to an increase in myelin sheath number per oligodendrocyte in the dorsal spinal cord (Supplementary Fig. 5 and data not shown). We next generated a p3E vector in which full length cast was flanked by p2A and a SV40 polyA sequences. We then generated a pME vector with the Fyn myristoylation domain added to GFP, by amplifying GFP from pCS2+eGFP and adding the myristoylation sequence using the following primer meGFPF 5’-ATGGGCTGTGTGCAATGTAAGGATAAAGAAGCAACAAAACTGACG-3.’ To generate a construct for cell type specific expression of meGFP-pA or meGFP-2A-cast-pA we recombined the previously described p5E-mbp plasmid containing zebrafish myelin basic protein regulatory sequence25, with the pME-meGFP and p3E-pA or with the pME-meGFP and p3E-2A-cast-pA. mbp:meGFP-pA (5pg) or mbp:meGFP-2A-cast-p2A (10pg) plasmids were injected into zebrafish at the 1-2 cell stage together with 25pg tol2 mRNA26. Individual oligodendrocytes were imaged at 4dpf using meGFP on a Zeiss 880 Airyscan confocal microscope in Fast Mode.
Statistics and reproducibility
All data are shown as mean ± standard deviation or median with 1st and 3rd quartiles as indicated. Please see Supplementary table 1 for data on confidence levels and intervals related to raw data. All statistical tests were carry out using GraphPad (Prism 6 or 7). Power calculations were calculated using Statemate 2 to determine for Ca2+ imaging analyses, and investigations of the role of calpain signalling in myelination. All analyses had a power >80%. Randomisation of imaging and analyses was not carried out on animals whose myelin sheaths were Ca2+ imaged, as all are wildtype. For chemical and genetic manipulations of calpain function, zebrafish embryos for both experimental and control conditions derived from the same clutch (per experiment). For time-lapse analyses of chemical inhibitor treated animals, control and experimental animals were imaged separately for technical reasons. Embryos were grown up in the same incubator and the same conditions prior to analyses, all live imaging. During live imaging analyses, experimental and control animals were imaged in an alternating pattern (per experiment) to ensure no confounding effects of stage of development between groups. The analysis of all experimental findings were carried out blinded and image data was randomised using a custom-made script.
The data shown in Supplementary Figure 1 is representative of 20 myelin sheaths imaged in 12 animals over 4 separate experimental sessions.
The data shown in Figure 1A-E and Supplementary Figure 2 are representative of 40 oligodendrocytes imaged in 40 animals over 25 separate occasions.
The images analysed and data presented in Figures 1G-K, 2A-D and Figure 3 are representative of 18 cells imaged over 9 separate experimental sessions.
The images analysed and data presented in Figure 2E,H are representative of 4 experimental sessions.
The images analysed and data presented in Figure 2G,J are representative of 4 experimental sessions.
The images analysed and data presented in Figure 2F,I are representative of 6 experimental sessions.
Data were tested for normality by the D'Agostino & Pearson omnibus normality test. Normal distributed data were tested as appropriate by two-tailed student’s t-test unpaired (equal variance was tested using the F test) or two-tailed one-way ANOVA (equal variance was tested using the Brown-Forsythe test). Non-normally distributed data were tested by a two-tailed Mann-Whitney tests. The Pearson’s correlation test was used to test the correlation in Fig.1J and Fig. 3D. Linear regression analyses were used to test whether the slopes differed significantly from zero in Fig. 3E. Throughout all analyses * p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
Please see Life Sciences Reporting Summary for further details on experimental design.
Data and code availability
Transgenic constructs and transgenic zebrafish lines will be available upon request. The data that support the findings of this study are available from the corresponding author upon reasonable request. Custom written code for analyses of Ca2+ imaging data are specific to the imaging platform, but details are available upon request. A custom written code for blinding of image analyses in Fiji/ImageJ is are available as a supplementary software item.
Supplementary Material
Acknowledgements
We would like to thank members of the Lyons lab, as well as Thomas Becker, Peter Brophy, Charles ffrench-Constant, Matthew Livesey, Dies Meijer, Will Talbot and Claire Wyart for helpful comments on the manuscript. We would like to thank Herwig Baier for transgenic zebrafish, Bertrand Vernay for support in image analysis. This work was supported by a Lister Institute Research Prize and a Wellcome Trust Senior Research Fellowship (102836/Z/13/Z) to DAL.
Footnotes
Accession codes
The Genbank accession number for calpastatin mRNA is MG387170.
Author contributions
MB designed and performed experiments and co-wrote manuscript. SK performed experiments using chemical inhibitors. DAL designed experiments, managed project and co-wrote manuscript.
Competing financial interests
I declare that the authors have no competing interests as defined by Springer Nature, or other interests that might be perceived to influence the results and/or discussion reported in this paper.
References
- 1.Chang K-J, Redmond SA, Chan JR. Nat Neurosci. 2016;19:190–197. doi: 10.1038/nn.4200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Czopka T, Ffrench-Constant C, Lyons DA. Developmental Cell. 2013;25:599–609. doi: 10.1016/j.devcel.2013.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Snaidero N, et al. Cell. 2014;156:277–290. doi: 10.1016/j.cell.2013.11.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Watkins TA, Emery B, Mulinyawe S, Barres BA. Neuron. 2008;60:555–569. doi: 10.1016/j.neuron.2008.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hines JH, Ravanelli AM, Schwindt R, Scott EK, Appel B. Nat Neurosci. 2015;18:683–689. doi: 10.1038/nn.3992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mensch S, et al. Nat Neurosci. 2015;18:628–630. doi: 10.1038/nn.3991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fields RD. Nat Rev Neurosci. 2015;16:756–767. doi: 10.1038/nrn4023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wake H, et al. Nature Communications. 2015;6:7844. doi: 10.1038/ncomms8844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Koudelka S, et al. Curr Biol. 2016;26:1447–1455. doi: 10.1016/j.cub.2016.03.070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wake H, Lee PR, Fields RD. Science. 2011;333:1647–1651. doi: 10.1126/science.1206998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sun W, Matthews EA, Nicolas V, Schoch S, Dietrich D. Elife. 2016;5 doi: 10.7554/eLife.16262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Micu I, et al. Experimental Neurology. 2016;276:41–50. doi: 10.1016/j.expneurol.2015.10.006. [DOI] [PubMed] [Google Scholar]
- 13.Chen T-W, et al. Nature. 2013;499:295–300. doi: 10.1038/nature12354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kanamori T, et al. Science. 2013;340:1475–1478. doi: 10.1126/science.1234879. [DOI] [PubMed] [Google Scholar]
- 15.Wang KK, et al. PNAS. 1996;93:6687–6692. [Google Scholar]
- 16.Moldoveanu T, Gehring K, Green DR. Nature. 2008;456:404–408. doi: 10.1038/nature07353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Campbell RL, Davies PL. Biochem J. 2012;447:335–351. doi: 10.1042/BJ20120921. [DOI] [PubMed] [Google Scholar]
- 18.Nawaz S, et al. Developmental Cell. 2015;34:139–151. doi: 10.1016/j.devcel.2015.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Pitman KA, Young KM. Int J Biochem Cell Biol. 2016;77:30–34. doi: 10.1016/j.biocel.2016.05.018. [DOI] [PubMed] [Google Scholar]
- 21.Almeida RG, Lyons DA. Zebrafish. 2015;12:377–386. doi: 10.1089/zeb.2015.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kirby BB, et al. Nat Neurosci. 2006;9:1506–1511. doi: 10.1038/nn1803. [DOI] [PubMed] [Google Scholar]
- 23.White RM, et al. Cell Stem Cell. 2008;2:183–189. doi: 10.1016/j.stem.2007.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kiss R, Kovács D, Tompa P, Perczel A. Biochemistry. 2008;47:6936–6945. doi: 10.1021/bi800201a. [DOI] [PubMed] [Google Scholar]
- 25.Almeida RG, Czopka T, Ffrench-Constant C, Lyons DA. Development. 2011;138:4443–4450. doi: 10.1242/dev.071001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kwan KM, et al. Dev Dyn. 2007;236:3088–3099. doi: 10.1002/dvdy.21343. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Transgenic constructs and transgenic zebrafish lines will be available upon request. The data that support the findings of this study are available from the corresponding author upon reasonable request. Custom written code for analyses of Ca2+ imaging data are specific to the imaging platform, but details are available upon request. A custom written code for blinding of image analyses in Fiji/ImageJ is are available as a supplementary software item.